Skip to content

Lucid Diagnostics LUCD Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$19.18M-30.5%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$2.12M+71.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$426K+84.5%
Labcorp Holdings logo
Labcorp HoldingsLH
-$27.4M+84.3%
Danaher logo
DanaherDHR
-$322M-38.2%
GRAIL, Inc. logo
GRAIL, Inc.GRAL
-$5.36M-72.8%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's change in accrued liabilities?
Lucid Diagnostics (LUCD) reported change in accrued liabilities of -$519K in Q1 2026.
How has Lucid Diagnostics's change in accrued liabilities changed year-over-year?
Lucid Diagnostics's change in accrued liabilities increased by 31.3% year-over-year, from -$756K to -$519K.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.